The adjustment in price target by a major analyst like Morgan Stanley can have a mixed impact. While maintaining an Overweight rating is positive and suggests confidence in the company's fundamentals, the reduction in price target might raise concerns about valuation or near-term headwinds. However, the impact is likely neutral in the short term as the reduction is minimal and the overall outlook remains positive.